Ulrich-Pur H, Kornek GV, Haider K, Kwasny W, Payrits T, Dworan N, et al. Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer. AO [Internet]. 2007 Jan. 1 [cited 2026 May 24];46(2):208-13. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26305